| P50 | author | Karen Vousden | Q6370108 |
| | Christine Dufès | Q56953346 |
| | Daniele Bergamaschi | Q62727094 |
| | Kevin M Ryan | Q37834605 |
| | Andreas Schätzlein | Q51629989 |
| P2093 | author name string | Xin Lu | |
| | Diane Crighton | |
| | Jim O'Prey | |
| | Helen S Bell | |
| P2860 | cites work | The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage | Q22010200 |
| | PUMA induces the rapid apoptosis of colorectal cancer cells | Q24291462 |
| | PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 |
| | ASPP proteins specifically stimulate the apoptotic function of p53 | Q24291844 |
| | ASPP1 and ASPP2: common activators of p53 family members | Q24305256 |
| | A model for p53-induced apoptosis | Q24313374 |
| | In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 |
| | Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 |
| | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| | Surfing the p53 network | Q28032484 |
| | Induction of apoptosis in HeLa cells by trans-activation-deficient p53 | Q53461564 |
| | p63 and p73 are required for p53-dependent apoptosis in response to DNA damage | Q59065672 |
| | Chemosensitivity linked to p73 function | Q73342473 |
| | 53BP2 induces apoptosis through the mitochondrial death pathway | Q28237734 |
| | KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene | Q28250929 |
| | Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 |
| | Live or let die: the cell's response to p53 | Q29547663 |
| | The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 |
| | p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 |
| | Evolution of functions within the p53/p63/p73 family. | Q34148139 |
| | iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. | Q34170068 |
| | The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. | Q34359755 |
| | The expression of iASPP in acute leukemias | Q34377630 |
| | On the shoulders of giants: p63, p73 and the rise of p53. | Q34511214 |
| | p53, p63 and p73--solos, alliances and feuds among family members | Q34515770 |
| | Apoptosis: a link between cancer genetics and chemotherapy | Q34520432 |
| | Therapeutic exploitation of the p53 pathway | Q34583882 |
| | p73: Friend or foe in tumorigenesis | Q34770297 |
| | Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. | Q34984251 |
| | TP53 family members and human cancers | Q35078717 |
| | The ASPP family: deciding between life and death after DNA damage | Q35082288 |
| | Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells | Q35088549 |
| | Splicing DNA-damage responses to tumour cell death. | Q35976600 |
| | p53 mutation heterogeneity in cancer | Q36113160 |
| | RETRACTED: p73alpha regulation by Chk1 in response to DNA damage | Q37056579 |
| | DNA-binding independent cell death from a minimal proapoptotic region of E2F-1. | Q38313722 |
| | Relief of p53-mediated telomerase suppression by p73. | Q38330053 |
| | Viral oncoproteins discriminate between p53 and the p53 homolog p73. | Q39576424 |
| | Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. | Q40372923 |
| | Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells | Q40410781 |
| | p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation | Q40614201 |
| | The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. | Q40710593 |
| | Episomal vectors rapidly and stably produce high-titer recombinant retrovirus | Q42810400 |
| | The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo. | Q47603890 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1008-1018 | |
| P577 | publication date | 2007-03-08 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo | |
| P478 | volume | 117 | |